Health Canada

Health Canada

October 11, 2013 20:52 ET

Natural Health Product (Spectrazyme) Recalled Due to Potential Contamination with the Antibiotic Chloramphenicol

ONTARIO, OTTAWA--(Marketwired - Oct. 11, 2013) -

The issue:

Metagenics Canada, in consultation with Health Canada, is voluntarily recalling its natural health product "Spectrazyme" - a digestive aid - due to a possible contamination with chloramphenicol, an antibiotic that may pose serious health risks to consumers. Chloramphenicol is associated with a rare risk of aplastic anemia, a serious blood disorder that can be fatal. This reaction is unpredictable and not related to a specific dose of chloramphenicol.

Chloramphenicol is a prescription drug and should only be used under medical supervision in adults and children after careful consideration of the risks associated with it use. Other side effects that can be associated with chloramphenicol include allergic reactions in people who have sensitivity to the medication, and effects on the bone marrow leading to decreased blood cells. In addition, it should not be used in pregnant or lactating women.

Who is affected: Canadians who have used this product. The company has not received any reports of adverse reactions associated with this product.

What consumers should do:

- Consult your healthcare practitioner immediately if you have used this product.

- Report any adverse events using this product to Health Canada.

- Contact Metagenics Canada Inc. at 1-800-268-6200 to return the product.

What Health Canada is doing:

Health Canada is monitoring the recall of "Spectrazyme" by the company.

According to the company, testing of one of the raw materials used to produce this product identified the presence of chloramphenicol.

Products affected:

  1. Spectrazyme (NPN 80044751) Lot #0413083

A photo of the product is available at the following address:

For more information:

Consumers and health professionals wanting more information about this advisory from Health Canada can contact the Public Enquiries Line at 613-957-2991, or toll free at 1-866-225-0709.

Media enquiries related to this Advisory should be directed to Health Canada Media Relations at 613-957-2983.

How to report side effects to health products:

To report suspected adverse reaction to these or other health products, please contact Health Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form and send to us using one of these methods:

Fax: 1-866-678-6789
Mail: Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, ON, Address Locator 0701E
K1A 0K9

Stay connected with Health Canada and receive the latest advisories and product recalls using these social media tools.

Également disponible en français

Contact Information

  • Media Inquiries:
    Health Canada
    (613) 957-2983

    Public Inquiries:
    (613) 957-2991